Quick Heal Technologies

Buy Date: 17-Dec-2021

Qty: 43 Price: ₹227.8 EPS: ₹14.69 PE:15.5

I will not add to this stock even when the price drops.

I have purchased this stock since it has zero debt and cash of around ₹332cr after the buyback.

Buyback Date: 25-Oct-2022 Holding days: 312

Qty:12 Price: ₹300 EPS: ₹11.12 PE: 26.97

Quick Heal Technologies is an India-based IT security solutions company. It is engaged in offering software security products and solutions. The company serves clients in various industries including manufacturing. BFSI, healthcare, hospitality, educational institutions, government organizations, emerging e-commerce, and the service sector. The group reports the operating segments based on the target customer groups to bring Retail; Enterprise and Government; and Mobile. It has a business presence in India and foreign countries, of which maximum revenue is derived within India. Its product range consists of Quick Heal Total Security, Quick Heal AntiVirus Pro, Quick Heal Total Security for Mac, Quick Heal PCTuner 3.0, and Guardian NetSecure.

Granules India update

PE was reasonable.

Buy PE of 19.64 is above 10 years PE median of 15.07.

Earnings have been increasing since 2012.

Return on equity is good at 27%.

Debt is 892.10cr and ₹393.80cr cash.

The market cap of the company is ₹7,831.48cr.

Buy date: 21-Dec-2020

Qty: 29   Buy Price: ₹342.3    Buy EPS: 17.42    Buy PE: 19.64

The stock has fallen 10% but the earnings improved so I have added 32 shares.

Buy date: 18-Mar-2021

Qty: 32   Buy Price: ₹307.75    Buy EPS: 20.53    Buy PE: 15.85

Q4 results were released on May 11th and the current EPS is 22.18 which increased by 27.32% and 8.04% from my buy EPS.

The price of the stock is down about -2.4% from my average buy price.

Buy date: 12-May-2022

Qty: 41   Buy Price: ₹239    Buy EPS:₹17.15    Buy PE: 13.93

Buyback: 17-Oct-2022

Qty: 29    Sold Price: ₹400    Sold EPS:₹16.89    Sold PE: 23.68

Granules India is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the emerging business focuses on manufacturing APIs and the US Generics. Its primary geographic markets are North America, Latin America, Europe, India, and the Rest of the World.

Disclaimer: The video is for educational purposes and for my friends and family. I am not a financial advisor and do not consider it as buy or sell. Taking advice from a random guy on the internet is harmful to your portfolio. I do not do a deep analysis of stocks I buy them just as a hobby.

Buyback

I have sold 15 shares at 600 of Gulf Oil Lubricants India in the buyback, initial entitlement was given as 4 shares for 57 shares I hold.

Folio No. / DP ID and Client ID	No. of Equity Shares held as on Record Date	Entitlement for Buy Back [No. of Equity Shares]
	57	4

15 shares were now taken as part of the buyback which is 26.31%. I made a profit of 3000 rupees and did purchase back 15 shares at 450 original purchase was at 580.

This buyback is profitable.